logo

Earkart Secures Patent for AI-Based Smart Sound Treatment System; Stock Rises About 5%

By Shishta Dutta | Published at: Oct 30, 2025 05:23 PM IST

Earkart Secures Patent for AI-Based Smart Sound Treatment System; Stock Rises About 5%
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

New Delhi, October 30, 2025: Earkart Ltd (BSE: 544549) shares surged almost 5% after the company announced that it has been granted a patent for its “Smart Sound Treatment and Diagnosis System and Method Thereof” by the Patent Office, Government of India.

Earkart Ltd, formerly known as Earkart Private Limited, operates in the medical equipment and supplies segment. The company focuses on hearing care solutions and smart health innovations. It is listed on the BSE SME platform under the ticker 544549 and continues to expand its footprint in the digital healthcare and assistive technology markets.

Patent Details

As per the company’s regulatory filing, the company has been granted a patent titled “Smart Sound Treatment and Diagnosis System and Method Thereof” bearing the patent number 572862. The patent has been granted for the jurisdiction of India on October 29, 2025, against the company’s application number 202211037078.

Through the patented system, the company now leverages acoustic signal processing, artificial intelligence (AI), and smart sensors. These technologies have the ability to detect and analyse sound patterns linked to health conditions, such as respiratory or cardiac signals. They can also deliver therapeutic sound treatments using targeted audio frequencies for recovery and relaxation.

In its filing for the patent, the company claimed that the innovation offers non-invasive, real-time, and affordable healthcare monitoring that can integrate with IoT-enabled medical devices or mobile health platforms.

Strategic Relevance

Showing enthusiasm regarding the approval, Earkart stated that the patent will strengthen its intellectual property portfolio in digital health and wellness. It will also enhance the company’s R&D capabilities and open opportunities for commercial deployment, licensing, or collaborations in the healthcare technology sector. The company further stated that the development aligns with Earkart’s broader vision of advancing AI- and sound-based diagnostic solutions within the growing smart healthcare ecosystem.

Market Snapshot

As of October 30, 2025, the share price of Earkart Limited closed at ₹229.70, a rise of 4.93% or 10.80 points. The shares opened in green at ₹229.80, and since had a steady session with traded volume at 0.40 lakhs and traded value of ₹0.92 crore, with the total market capitalisation of ₹315.93 crore.

REF: https://www.bseindia.com/xml-data/corpfiling/AttachLive/a109b575-d6b6-4afd-9082-e532f9761d8e.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy